BCVI launch event 2022

Tuesday 26th April 2022, 9am - 6pm  |  CRUK Cambridge Institute lecture theatre

Registrations have now closed, but please get in touch with Gill Kortum gsc30@cam.ac.uk to check for any last minute spaces

Outline programme

From April 2022, the Neuro-oncology Programme within the CRUK Cambridge Centre will be transforming to become the CRUK Brain Cancer Virtual Institute.

The BCVI will unite clinicians and researchers working to improve outcomes for brain tumour patients and their families. Working with partners including the CRUK RadNet programme, the CRUK Children's Brain Tumour Centre of Excellence and members across Cambridge, the BCVI will be driving forward new developments in brain tumour research.

Led by Mr Stephen Price and Mr Richard Mair, attendees will be invited to hear from a range of different research groups and programmes, as well as benefit from plenty of opportunities to network with researchers and clinicians.

*Confirmed speakers: Dr Richard Baird, Dr Omer Bayraktar, Dr Harry Bulstrode, Prof Charlotte Coles, Dr Pau Creixell, Dr Antonella De Cola, Prof Richard Gilbertson, Dr Petra Hamerlik, Dr Raj Jena, Dr Chao Li, Dr Juanita Lopez, Prof George Malliaras, Dr Eric Rahrmann, Dr Ana Rossi, Prof John Suckling, Dr Ana Tsyben, Dr Huiqi Yang*

Image credit: Pathania lab www.pathanialab.com

Outline programme

Registration and tea/coffee from 8.30am

9am - WELCOME -
9.10am Developmental Neurobiology session:

Prof Richard Gilbertson | "Deep learning for new therapies"

Dr Harry Bulstrode | “Zika Virus: Stem Cell Tropism and Microenvironment-induced Resistance”

Dr Antonella De Cola | “Identifying driver-specific vulnerabilities in paediatric high grade gliomas subtypes”

10.10am Imaging and Tumour Metabolism session:

Dr Anastasia Tsyben | “Imaging metabolic heterogeneity of Glioblastoma Multiforme”

Dr Chao Li | “Intelligent neuroimaging for precision neuro-oncology”

Prof John Suckling | “Imaging insights into the cognitive deficits and recovery of patients with brain tumours”

11.10am - MORNING BREAK -
11.30am Heterogeneity, recurrence, transformation and treatment resistance session:

Mr Richard Mair | "Exploring cancer heterogeneity with cell free DNA"

Dr Omer Bayraktar | "GBM-space: dissecting the cellular circuits of glioblastoma using single cell and spatial genomics"

Dr Ana Rossi | “IP3R, invasiveness and resistance to therapy in GBM: therapeutic opportunities?”

12.30pm - LUNCH -
2pm Brain Metastases session:

Dr Eric Rahrmann | “The Nalcn channel regulates metastatic disease”

Dr Huiqi Yang | “REFORMing the use of surgery and radiosurgery in cerebral oligometastatic disease”

Dr Richard Baird | “CamBMT1 and BoB: the Cambridge Brain Mets Trial 1 and Cancer Core Europe Basket of Baskets trial"

3pm Therapies session:

Prof Charlotte Coles & Dr Raj Jena | "CRUK RadNet Cambridge"

Dr Pau Creixell | “Collateral sensitivity”

Dr Petra Hamerlik | “Targeting DNA Repair in Glioblastoma: New Era of Brain Penetrant Agents”

Prof George Malliaras | “New Targeted Delivery Technologies for Hard-to-Treat Cancers”

4.40pm Clinical trials

Dr Juanita Lopez | "Disruption Innovation: Acceleration of drug development for brain tumours"

5pm Bringing the Virtual Institute to the clinic session:

Mr Stephen Price | "Individualising care for the patient in front of us"

Mr Richard Mair | "Individualising care for the patient of the future"